Subclinical Primary Aldosteronism and Cardiovascular Health: A Population-Based Cohort Study

Author:

Hundemer Gregory L.12ORCID,Agharazii Mohsen3ORCID,Madore François4,Vaidya Anand5ORCID,Brown Jenifer M.6ORCID,Leung Alexander A.78ORCID,Kline Gregory A.7ORCID,Larose Eric9ORCID,Piché Marie-Eve10,Crean Andrew M.11ORCID,Shaw Julie L.V.1213,Ramsay Tim2,Hametner Bernhard14ORCID,Wassertheurer Siegfried14ORCID,Sood Manish M.12ORCID,Hiremath Swapnil12ORCID,Ruzicka Marcel12ORCID,Goupil Rémi4

Affiliation:

1. Department of Medicine, Division of Nephrology, University of Ottawa, Ontario, Canada (G.L.H., M.M.S., S.H., M.R.).

2. Clinical Epidemiology Program, Ottawa Hospital Research Institute, Ontario, Canada (G.L.H., T.R., M.M.S., S.H., M.R.).

3. Department of Medicine, Division of Nephrology, CHU de Québec-Université Laval, Quebec City, Canada (M.A.).

4. Department of Medicine, Division of Nephrology, Hôpital du Sacré-Coeur de Montréal, Université de Montréal, Quebec, Canada (F.M., R.G.).

5. Center for Adrenal Disorders, Division of Endocrinology, Diabetes, and Hypertension (A.V.), Brigham and Women’s Hospital, Harvard Medical School, Boston, MA.

6. Division of Cardiovascular Medicine (J.M.B.), Brigham and Women’s Hospital, Harvard Medical School, Boston, MA.

7. Department of Medicine, Division of Endocrinology and Metabolism (A.A.L., G.A.K.), Cumming School of Medicine, University of Calgary, Alberta, Canada.

8. Department of Community Health Sciences (A.A.L.), Cumming School of Medicine, University of Calgary, Alberta, Canada.

9. Department of Medicine, Division of Cardiology, Université Laval, Quebec City, Canada (E.L., M.-E.P.).

10. Institut Universitaire de Cardiologie et de Pneumologie de Québec-Université Laval, Quebec City, Canada (E.L., M.-E.P.).

11. Division of Cardiovascular Medicine, Ottawa Heart Institute, Ontario, Canada (A.M.C.).

12. Department of Pathology and Laboratory Medicine, Division of Biochemistry, Ottawa Hospital, Ontario, Canada (J.L.V.S.).

13. Eastern Ontario Regional Laboratories Association, Ottawa, Canada (J.L.V.S.).

14. Center for Health & Bioresources, AIT Austrian Institute of Technology, Vienna, Austria (B.H., S.W.).

Abstract

BACKGROUND: Primary aldosteronism, characterized by overt renin-independent aldosterone production, is a common but underrecognized form of hypertension and cardiovascular disease. Growing evidence suggests that milder and subclinical forms of primary aldosteronism are highly prevalent, yet their contribution to cardiovascular disease is not well characterized. METHODS: This prospective study included 1284 participants between the ages of 40 and 69 years from the randomly sampled population-based CARTaGENE cohort (Québec, Canada). Regression models were used to analyze associations of aldosterone, renin, and the aldosterone-to-renin ratio with the following measures of cardiovascular health: arterial stiffness, assessed by central blood pressure (BP) and pulse wave velocity; adverse cardiac remodeling, captured by cardiac magnetic resonance imaging, including indexed maximum left atrial volume, left ventricular mass index, left ventricular remodeling index, and left ventricular hypertrophy; and incident hypertension. RESULTS: The mean (SD) age of participants was 54 (8) years and 51% were men. The mean (SD) systolic and diastolic BP were 123 (15) and 72 (10) mm Hg, respectively. At baseline, 736 participants (57%) had normal BP and 548 (43%) had hypertension. Higher aldosterone-to-renin ratio, indicative of renin-independent aldosteronism (ie, subclinical primary aldosteronism), was associated with increased arterial stiffness, including increased central BP and pulse wave velocity, along with adverse cardiac remodeling, including increased indexed maximum left atrial volume, left ventricular mass index, and left ventricular remodeling index (all P <0.05). Higher aldosterone-to-renin ratio was also associated with higher odds of left ventricular hypertrophy (odds ratio, 1.32 [95% CI, 1.002–1.73]) and higher odds of developing incident hypertension (odds ratio, 1.29 [95% CI, 1.03–1.62]). All the associations were consistent when assessing participants with normal BP in isolation and were independent of brachial BP. CONCLUSIONS: Independent of brachial BP, a biochemical phenotype of subclinical primary aldosteronism is negatively associated with cardiovascular health, including greater arterial stiffness, adverse cardiac remodeling, and incident hypertension.

Publisher

Ovid Technologies (Wolters Kluwer Health)

Subject

Physiology (medical),Cardiology and Cardiovascular Medicine

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3